| View |
|
DRP-1234-02
|
Atorvastatin (as calcium)
|
Avamax
|
20 mg
|
Film-Coated Tablet
|
Antihypercholesterolemia
|
Ranbaxy (M) Sdn. Bhd
|
Malaysia
|
Renewal
|
16 January 2024
|
02 February 2029
|
| View |
|
DRP-4428-01
|
Medroxyprogesterone Acetate
|
Feroxyron
|
5 mg
|
Tablet
|
-
|
Unicure Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
13 December 2022
|
23 May 2028
|
| View |
|
DRP-4762-07
|
Telmisartan
|
Vas8
|
80mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Scott-Edil Pharmacia Ltd.
|
India
|
Renewal
|
24 January 2024
|
30 September 2028
|
| View |
|
DRP-9416-01
|
Iohexol
|
Hexolfree 300
|
647 mg/mL (eq. to 300 mg/mL Iodine)
|
Solution for Injection (Intrathecal/Intravascular/Intraarticular/Oral or Rectal Administration/Oral in Conjunction with Intravenous Administration/Body Cavity)
|
-
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
13 December 2022
|
23 December 2025
|
| View |
|
DRP-9615-02
|
Telmisartan
|
None
|
80 mg
|
Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
13 December 2022
|
25 March 2026
|
| View |
|
DRP-10631-06
|
Vancomycin (as hydrochloride)
|
None
|
1 g
|
Powder for Injection (IV)
|
-
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
13 December 2022
|
10 November 2026
|
| View |
|
DRP-11080-04
|
Ceftriaxone (as Sodium) + Sulbactam (as Sodium)
|
Ceftribac
|
1g/500mg
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
13 December 2022
|
26 January 2027
|
| View |
|
DRP-11463-03
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazohil 2.25
|
2 g / 250 mg
|
Powder for Injection (I.V.)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
13 December 2022
|
15 March 2027
|
| View |
|
DRP-11625-01
|
Mupirocin
|
Pucinfree
|
20 mg/g (2% w/w)
|
Ointment
|
-
|
Next Wave (India)
|
India
|
CLIDP Conversion
|
13 December 2022
|
04 April 2027
|
| View |
|
DRP-10631-05
|
Vancomycin (as hydrochloride)
|
None
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Glycopeptide)
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
12 December 2022
|
10 November 2026
|
| View |
|
DRP-4072-10
|
Cefixime (as trihydrate)
|
Cefzin-S
|
200 mg
|
Film-Coated Tablet
|
-
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
08 December 2022
|
24 October 2027
|
| View |
|
DRP-4816-01
|
Levetiracetam
|
Malcetam
|
500 mg
|
Film-Coated Tablet
|
Antiepileptic
|
PharmEvo (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
08 December 2022
|
14 October 2028
|
| View |
|
DRP-5798-02
|
Etoricoxib
|
Akticib
|
60 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Zim Laboratories Limited
|
India
|
Renewal
|
19 April 2024
|
17 November 2029
|
| View |
|
DRP-5930-06
|
Omeprazole Sodium
|
Omerife
|
40 mg
|
Lyophilized Powder for Injection
|
-
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
Renewal
|
22 December 2023
|
05 December 2028
|
| View |
|
DRP-6148-01
|
Amlodipine (as besilate)
|
Malapine-5
|
5 mg
|
Tablet
|
-
|
Medisure Laboratories Pakistan (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
08 December 2022
|
11 May 2025
|
| View |
|
DRP-6195-05
|
Mupirocin
|
Mupicent
|
20 mg/g (2% w/w)
|
Ointment
|
-
|
Scott-Edil Pharmacia Ltd.
|
India
|
CLIDP Conversion
|
08 December 2022
|
24 June 2025
|
| View |
|
DRP-6558-04
|
Dibencozide
|
Cozin
|
3 mg
|
Capsule
|
Vitamins
|
LifeSquare Laboratories Inc
|
Philippines
|
Renewal
|
19 February 2024
|
03 March 2029
|
| View |
|
DRP-8929-12
|
Norepinephrine(as bitartrate)
|
Norephilz
|
1mg/mL (4mg/4mL)
|
Solution for Injection(I.V.)
|
-
|
BCWorld Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
08 December 2022
|
29 June 2025
|
| View |
|
DRP-13178
|
Simvastatin
|
Vamstat
|
20 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
PCPR Conversion
|
16 December 2022
|
07 February 2025
|
| View |
|
DRP-13179
|
Glutathione
|
Sitiglow
|
600mg
|
Lyophilized Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
PCPR Conversion
|
15 December 2022
|
14 November 2027
|